230 related articles for article (PubMed ID: 3035025)
61. Experimental autoimmune myasthenia gravis in the mouse.
Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
Curr Protoc Immunol; 2013; Chapter 15():Unit 15.8.. PubMed ID: 23392639
[TBL] [Abstract][Full Text] [Related]
62. Immunisation with Torpedo acetylcholine receptor.
Elfman L
Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937
[TBL] [Abstract][Full Text] [Related]
63. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
Ashizawa T; Elias SB; Appel SH
Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
[TBL] [Abstract][Full Text] [Related]
64. [Observation on the changes in the frequency of end-plate potentials evoked by sera with different antibodies from patients with myasthenia gravis in nerve-muscle preparation of rats].
Lu C
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):44-6, 63. PubMed ID: 1317284
[TBL] [Abstract][Full Text] [Related]
65. Antibodies to motor endplates demonstrated with the immunofluorescence technique.
Sondag-Tschroots IR; Schulz-Raateland RC; van Walbeek HK; Feltkamp TE
Clin Exp Immunol; 1979 Aug; 37(2):323-7. PubMed ID: 387311
[TBL] [Abstract][Full Text] [Related]
66. The nicotinic acetylcholine receptor: structure and autoimmune pathology.
Conti-Tronconi BM; McLane KE; Raftery MA; Grando SA; Protti MP
Crit Rev Biochem Mol Biol; 1994; 29(2):69-123. PubMed ID: 8026215
[TBL] [Abstract][Full Text] [Related]
67. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.
Lennon VA; Seybold ME; Lindstrom JM; Cochrane C; Ulevitch R
J Exp Med; 1978 Apr; 147(4):973-83. PubMed ID: 206648
[TBL] [Abstract][Full Text] [Related]
68. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
Lambert EH; Lindstrom JM; Lennon VA
Ann N Y Acad Sci; 1976; 274():300-18. PubMed ID: 1066990
[TBL] [Abstract][Full Text] [Related]
69. Properties of end-plate channels in rats immunized against acetylcholine receptors.
Alemà S; Cull-Candy SG; Miledi R; Trautmann A
J Physiol; 1981 Feb; 311():251-66. PubMed ID: 6267252
[TBL] [Abstract][Full Text] [Related]
70. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
Serra A; Ruff R; Kaminski H; Leigh RJ
Ann N Y Acad Sci; 2011 Sep; 1233():26-33. PubMed ID: 21950972
[TBL] [Abstract][Full Text] [Related]
71. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
Oda K; Shibasaki H
Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
[TBL] [Abstract][Full Text] [Related]
72. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
Zahm DS; Kim YI; Liu HH; Johns TR
Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
[TBL] [Abstract][Full Text] [Related]
73. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
Engel AG
Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
[No Abstract] [Full Text] [Related]
74. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
[TBL] [Abstract][Full Text] [Related]
75. Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunization.
Wu X; Tuzun E; Li J; Xiao T; Saini SS; Qi H; Allman W; Christadoss P
Muscle Nerve; 2012 Feb; 45(2):209-16. PubMed ID: 22246876
[TBL] [Abstract][Full Text] [Related]
76. The relationship between anti-acetylcholine receptor antibody levels and neuromuscular function in chronically myasthenic rats.
Gallant PE
J Neurol Sci; 1982 Apr; 54(1):129-41. PubMed ID: 6281392
[TBL] [Abstract][Full Text] [Related]
77. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.
Simpson JA
Muscle Nerve; 1978; 1(2):151-6. PubMed ID: 220530
[TBL] [Abstract][Full Text] [Related]
78. Effects of D-penicillamine on neuromuscular transmission in rats.
Aldrich MS; Kim YI; Sanders DB
Muscle Nerve; 1979; 2(3):180-5. PubMed ID: 228187
[TBL] [Abstract][Full Text] [Related]
79. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
Mossman S; Vincent A; Newsom-Davis J
J Neurol Sci; 1988 Mar; 84(1):15-28. PubMed ID: 2835437
[TBL] [Abstract][Full Text] [Related]
80. Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies.
Slater CR; Young C; Wood SJ; Bewick GS; Anderson LV; Baxter P; Fawcett PR; Roberts M; Jacobson L; Kuks J; Vincent A; Newsom-Davis J
Brain; 1997 Sep; 120 ( Pt 9)():1513-31. PubMed ID: 9313636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
